MyFinsight
Home
Blog
About
Contact
Download
Download image
Inventories, net
$206,465K
Accounts receivable, net
$158,429K
Cash and cash
equivalents
$87,630K
Prepaid expenses and
other current assets
$7,458K
Assets held for sale
$6,530K
Property and equipment,
gross
$103,405K
Total current assets
$466,512K
Deferred tax assets, net
$73,261K
Property and equipment,
net
$65,057K
Deposits and other assets
$8,600K
Right-of-use assets
$6,650K
Goodwill
$3,530K
Intangible assets, net
$632K
Less accumulated
depreciation
$38,348K
Total assets
$624,242K
Total liabilities and
stockholders equity
$624,242K
Total stockholders
equity
$477,320K
Total liabilities
$146,922K
Accumulated deficit
-$161,653K
Treasury stock, at cost,
1,919,070 and 0 shares as of...
$32,090K
Additional paid-in capital
$671,039K
Total current
liabilities
$69,541K
Long-term debt
$69,330K
Lease obligations,
net of current...
$6,646K
Deferred revenue, net of
current portion
$1,405K
Common stock - voting,
0.0001 par value,...
$24K
Accrued expenses and
other current...
$40,466K
Accounts payable
$22,519K
Current portion of
long-term debt
$2,813K
Liabilities held for sale
$2,647K
Current portion of lease
obligations
$1,096K
Back
Back
Balance Sheet
source: myfinsight.com
ADMA BIOLOGICS, INC. (ADMA)
ADMA BIOLOGICS, INC. (ADMA)